MARISSA MAGGIOLI: Open Payments
NPI 1356186936 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$810 in 31 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $121 · 2025 $810
Food & beverage: $636Education: $174
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $137 |
| Novartis Pharmaceuticals Corporation | 7 | $132 |
| Aveo Pharmaceuticals, Inc. | 1 | $99 |
| SEAGEN INC. | 1 | $75 |
| Eisai Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $36 |
| Rigel Pharmaceuticals, Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
Products named: Jakafi, FOTIVDA, KISQALI, Lenvima, TAVALISSE, LUTATHERA, Enhertu, VENCLEXTA.
Industry payments across NY — which companies pay providers there.
